Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Adenosine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.82 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.82 |
| ▸ | P2RY1 | P47900 | 7/20 | 0.93 |
| ▸ | P2RX1 | P51575 | 4/20 | 0.93 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.93 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.93 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.93 |
| ▸ | SRC | P12931 | 2/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.93 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.93 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.93 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.87 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.86 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.86 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.86 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.86 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.82 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.82 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.82 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL7200593 | 1.00 | P2RY1 (0.93) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| SCHEMBL9171542 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL20550531 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL8979 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL12789528 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL2227081 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| SCHEMBL376008 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL18784961 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Diphosphate SCHEMBL8321453 | 0.99 | P2RY1 (0.91) | P2RY1P2RX1P2RX3P2RY2P2RX2 | |
| Adenosine Triphosphate SCHEMBL6242713 | 0.99 | P2RY1 (0.94) | P2RY1P2RX1P2RX3P2RY2P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116657124-B | Film forming auxiliary agent for water-based solder ball surface treating agent | 北华航天工业学院 | 2026-05-12 | — | — | CN | claimed |
| CN-117229953-A | Strain for efficiently degrading anionic surfactant alpha-sodium olefin sulfonate and application thereof | 信阳农林学院 | 2023-12-15 | — | — | CN | claimed |
| CN-116657124-A | Film forming auxiliary agent for water-based solder ball surface treating agent | 北华航天工业学院 | 2023-08-29 | — | — | CN | claimed |
| CN-116657124-B | Film forming auxiliary agent for water-based solder ball surface treating agent | 北华航天工业学院 | 2026-05-12 | — | — | CN | disclosed |
| US-12573656-B2 | Sintering aid mixture, solid-state ion conductor, and method for producing solid-state ion conductors | SCHOTT AG (DE) | 2026-03-10 | — | — | US | disclosed |
| US-12544412-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | PENDULUM THERAPEUTICS INC (US) | 2026-02-10 | — | — | US | disclosed |
| US-12343360-B2 | Methods and compositions for microbial engraftment | PENDULUM THERAPEUTICS INC (US) | 2025-07-01 | — | — | US | disclosed |
| CN-118655664-B | CPO module | 易栅光电(杭州)有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20240307466-A1 | Methods and Compositions Relating to Microbial Treatment and Diagnosis of Disorders | Pendulum Therapeutics, Inc. | 2024-09-19 | — | — | US | disclosed |
| CN-118655664-A | CPO module | 易栅光电(杭州)有限公司 | 2024-09-17 | — | — | CN | disclosed |
| US-11931387-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | Pendulum Therapeutics, Inc. (US) | 2024-03-19 | — | — | US | disclosed |
| CN-116657124-A | Film forming auxiliary agent for water-based solder ball surface treating agent | 北华航天工业学院 | 2023-08-29 | — | — | CN | disclosed |
| US-11583558-B2 | Methods and compositions for treatment of microbiome-associated disorders | Pendulum Therapeutics, Inc. (US) | 2023-02-21 | — | — | US | disclosed |
| WO-2022178159-A1 | COMPOSITIONS COMPRISING HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF | PROMETHEUS BIOSCIENCES, INC. (US) | 2022-08-25 | — | — | WO | disclosed |
| US-20220211780-A1 | Methods And Compositions For Treating Liver Disorders | Pendulum Therapeutics, Inc. | 2022-07-07 | — | — | US | disclosed |
| US-11364270-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | Pendulum Therapeutics, Inc. (US) | 2022-06-21 | — | — | US | disclosed |
| CN-114606351-A | Metal-free tanning method for light-colored leather based on glutaraldehyde composition | 珍寿实业(商丘)有限公司 | 2022-06-10 | — | — | CN | disclosed |
| EP-3973047-A1 | METHODS AND COMPOSITIONS FOR TREATING LIVER DISORDERS | Pendulum Therapeutics, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11278580-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | Pendulum Therapeutics, Inc. (US) | 2022-03-22 | — | — | US | disclosed |
| US-20220037694-A1 | SINTERING AID MIXTURE, SOLID-STATE ION CONDUCTOR, AND METHOD FOR PRODUCING SOLID-STATE ION CONDUCTORS | SCHOTT AG (DE) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11931387-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | FAH, LIPC, ASAH2 | ADRB2 4284/4885KCNH2 4673/4885P2RY1 1118/4885 |
| US-20240307466-A1 | Methods and Compositions Relating to Microbial Treatment and Diagnosis of Disorders | FAH, LIPC, ASAH2 | ADRB2 4284/4885KCNH2 4673/4885P2RY1 1118/4885 |
| US-12573656-B2 | Sintering aid mixture, solid-state ion conductor, and method for producing solid-state ion conductors | HCN4, SCN4A, SMARCC2 | ADRB2 1819/4885KCNH2 32/4885P2RY1 4021/4885 |
| US-11583558-B2 | Methods and compositions for treatment of microbiome-associated disorders | FABP2, FADS1, ELOVL1 | ADRB2 3452/4885KCNH2 4297/4885P2RY1 643/4885 |
| US-12544412-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | MUC1, SPOUT1, TAS2R14 | ADRB2 3285/4885KCNH2 2752/4885P2RY1 378/4885 |
| US-11278580-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | FAH, LIPC, ASAH2 | ADRB2 4284/4885KCNH2 4673/4885P2RY1 1118/4885 |
| US-11364270-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | FAH, LIPC, ASAH2 | ADRB2 4284/4885KCNH2 4673/4885P2RY1 1118/4885 |
| US-12343360-B2 | Methods and compositions for microbial engraftment | FABP2, CD47, HLA-DRB1 | ADRB2 3457/4885KCNH2 4546/4885P2RY1 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.